132 related articles for article (PubMed ID: 773679)
1. Trials of 3,7-dimethyl-1-(5-oxohexyl) xanthine (BL 191) in double-blind tests.
Buckert D; Harwart D
Farmaco Prat; 1976 May; 31(5):264-74. PubMed ID: 773679
[No Abstract] [Full Text] [Related]
2. [Results of a clinical study on the vasodilator 3,7-dimethyl-1-(5-oxo-hexyl)-xanthine (BL 191)].
Lehrach F; Müller R
Arzneimittelforschung; 1971 Aug; 21(8):1171-4. PubMed ID: 5110012
[No Abstract] [Full Text] [Related]
3. Cosaldon for vascular disorders?
Drug Ther Bull; 1972 Aug; 10(17):66-8. PubMed ID: 4570865
[No Abstract] [Full Text] [Related]
4. [Ginkgo-biloba in the therapy of vascular diseases].
Sorbini E
Minerva Med; 1973 Nov; 64(79 Suppl):4201-8. PubMed ID: 4592298
[No Abstract] [Full Text] [Related]
5. [Cerebral circulatory insufficiency. Value of a metabolic active drug].
Girard PE; Boucher M
Therapeutique; 1973; 49(5):397-400. PubMed ID: 4781833
[No Abstract] [Full Text] [Related]
6. [Controlled clinical study of use of dihydroergocristine in cerebral and periferal vascular disorders].
Calisti G; Biscarini L; Miseo A
Clin Ter; 1977 Nov; 83(4):371-86. PubMed ID: 414875
[No Abstract] [Full Text] [Related]
7. [Double-blind study based upon a quatitative appreciation scale of treating chronic cerebrovascular disorders].
Mémin Y; Najean Hueber E
Therapeutique; 1973 Nov; 49(9):605-8. PubMed ID: 4600040
[No Abstract] [Full Text] [Related]
8. [Therapy of peripheral arterial circulation disorders using 3,7-dimethyl-1-(5-oxo-hexyl)-xanthine (BL 191)].
Denck H
Arzneimittelforschung; 1973 Apr; 23(4):571-3. PubMed ID: 4740236
[No Abstract] [Full Text] [Related]
9. [Clinical studies on the effect of hexobendine (Ustimon) on cerebral circulatory disorders].
Prosenz P; Tschabitscher H
Wien Klin Wochenschr; 1965 Dec; 77(48):953-5. PubMed ID: 5331101
[No Abstract] [Full Text] [Related]
10. [Clinical considerations on the use of a drug with vasodilating hemokinetic action in cerebral and peripheral vascular diseases].
Florio F; Ruffolo S; Piro E
Minerva Cardioangiol; 1976 Feb; 24(2):161-70. PubMed ID: 1256656
[No Abstract] [Full Text] [Related]
11. [Critical observations on vasodilator agents in peripheral vascular diseases and cerebrovascular disorders].
Hamming JJ; van der Drift JH
Ned Tijdschr Geneeskd; 1968 Mar; 112(13):611-4. PubMed ID: 5664995
[No Abstract] [Full Text] [Related]
12. [On the treatment of cerebral nutrition disorders. A double blind study].
Kirchberger F; Kehl R; Gutmann W
Med Welt; 1969 Jul; 27():1542-6. PubMed ID: 4895204
[No Abstract] [Full Text] [Related]
13. Responsiveness of various symptoms of vascular disorders to calcium antagonist.
Verhaegen H; Reyntjens A; Horig C; Pötsch W
Angiology; 1979 Jul; 30(7):447-53. PubMed ID: 380409
[No Abstract] [Full Text] [Related]
14. [On the therapy of central and peripheral blood circulation disorders].
Weihrauch H
Hippokrates; 1967 Sep; 38(18):739-42. PubMed ID: 5610064
[No Abstract] [Full Text] [Related]
15. Proxazole in cerebrovascular insufficiency. A controlled clinical trial.
Esposito G; De Gregorio M
Arzneimittelforschung; 1974 Oct; 24(10):1692-6. PubMed ID: 4611436
[No Abstract] [Full Text] [Related]
16. [Use of peripheral vasodilator drug in peripheral and cerebrovascular syndromes of old age].
Andalò L; Missana M
Clin Ter; 1975 Sep; 74(5):471-84. PubMed ID: 819202
[No Abstract] [Full Text] [Related]
17. [Benfurodil hemisuccinate in cerebrovascular pathology].
Lehembre P; Warot P
Lille Med; 1974 Apr; 19(4 Suppl 11):525-7. PubMed ID: 4612281
[No Abstract] [Full Text] [Related]
18. [Experiences with the new vasotherapeutic drug Trental in dermatology].
Herger R
Fortschr Med; 1972 Aug; 90(24):865-72. PubMed ID: 4639351
[No Abstract] [Full Text] [Related]
19. [Cerebrovascular insufficiency].
Weser C
Z Arztl Fortbild (Jena); 1982 Apr; 76(8):343-6. PubMed ID: 7113277
[No Abstract] [Full Text] [Related]
20. [On the therapy of cerebral and peripheral circulatory disorders in general practice].
Risse S
Med Welt; 1967 Jul; 28():1659-62. PubMed ID: 5612140
[No Abstract] [Full Text] [Related]
[Next] [New Search]
